242 related articles for article (PubMed ID: 15985015)
1. Liver enzymes elevation after HAART in HIV-HCV co-infection.
Servin-Abad L; Molina E; Baracco G; Arosemena L; Regev A; Jeffers L; Schiff E
J Viral Hepat; 2005 Jul; 12(4):429-34. PubMed ID: 15985015
[TBL] [Abstract][Full Text] [Related]
2. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad;
AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
[TBL] [Abstract][Full Text] [Related]
4. Grade 3-4 liver enzyme elevation during HAART in HIV and hepatitis C co-infected adults.
Yunihastuti E; Gani RA; Lesmana LA; Sundaru H; Djauzi S
Acta Med Indones; 2009 Jul; 41(3):130-5. PubMed ID: 19752485
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
[TBL] [Abstract][Full Text] [Related]
6. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
[TBL] [Abstract][Full Text] [Related]
7. Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.
Meraviglia P; Schiavini M; Castagna A; Viganò P; Bini T; Landonio S; Danise A; Moioli MC; Angeli E; Bongiovanni M; Hasson H; Duca P; Cargnel A
HIV Med; 2004 Sep; 5(5):334-43. PubMed ID: 15369508
[TBL] [Abstract][Full Text] [Related]
8. Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients.
Stone SF; Lee S; Keane NM; Price P; French MA
J Infect Dis; 2002 Nov; 186(10):1498-502. PubMed ID: 12404169
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART.
Jevtović Dj; Ranin J; Salemović D; Pesić I; Dragović G; Zerjav S; Djurković-Djaković O
Biomed Pharmacother; 2008 Jan; 62(1):21-5. PubMed ID: 17223307
[TBL] [Abstract][Full Text] [Related]
10. Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients.
Vergara S; Macías J; Mira JA; García-García JA; Merchante N; del Valle J; Abdel-Kader L; Lozano F; Gómez-Mateos JM; Pineda JA
J Antimicrob Chemother; 2007 Jan; 59(1):87-91. PubMed ID: 17095528
[TBL] [Abstract][Full Text] [Related]
11. Severe transaminitis after interferon-ribavirin therapy in HIV/HCV-coinfected patients: influence of a sustained HCV response.
Bani-Sadr F; Krastinova E; Fromentin D; Piroth L; Rosenthal E; Quertainmont Y; Perronne C; Cacoub P; Pol S; Carrat F;
J Viral Hepat; 2012 Jun; 19(6):431-5. PubMed ID: 22571905
[TBL] [Abstract][Full Text] [Related]
12. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
[TBL] [Abstract][Full Text] [Related]
13. Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.
Torti C; Lapadula G; Uccelli MC; Quiros-Roldan E; Regazzi M; Ladisa N; Micheli V; Orani A; Patroni A; Caputo SL; Tirelli V; Di Giambenedetto S; Cologni G; Costarelli S; Gargiulo F; Manca N; Carosi G;
Int J Antimicrob Agents; 2007 Feb; 29(2):185-90. PubMed ID: 17011754
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study.
Manosuthi W; Chumpathat N; Chaovavanich A; Sungkanuparph S
BMC Infect Dis; 2005 Aug; 5():67. PubMed ID: 16120209
[TBL] [Abstract][Full Text] [Related]
15. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
Tornero C; Alberola J; Tamarit A; Navarro D
Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
[TBL] [Abstract][Full Text] [Related]
16. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
[TBL] [Abstract][Full Text] [Related]
17. Liver enzyme elevation in hepatitis C virus (HCV)-HIV-coinfected patients prior to and after initiating HAART: role of HCV genotypes.
Maida I; Babudieri S; Selva C; D'Offizi G; Fenu L; Solinas G; Narciso P; Mura MS; Núñez M
AIDS Res Hum Retroviruses; 2006 Feb; 22(2):139-43. PubMed ID: 16478395
[TBL] [Abstract][Full Text] [Related]
18. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
Mehta SH; Thomas DL; Torbenson M; Brinkley S; Mirel L; Chaisson RE; Moore RD; Sulkowski MS
Hepatology; 2005 Jan; 41(1):123-31. PubMed ID: 15619237
[TBL] [Abstract][Full Text] [Related]
19. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine. Prometheus Study Group.
Gisolf EH; Dreezen C; Danner SA; Weel JL; Weverling GJ;
Clin Infect Dis; 2000 Nov; 31(5):1234-9. PubMed ID: 11073757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
